BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Nov 27, 2026; 18(11): 124439
Published online Nov 27, 2026. doi: 10.4254/wjh.124439
Association between fibrosis-4 index and all-cause mortality by hepatic steatosis category in United States adults: A retrospective cohort study
Jing Lu, Zhao-Yun Liu, Chao Guo, Qing-Quan Gong
Jing Lu, Chao Guo, Qing-Quan Gong, Department of Gastroenterology, Mindong Hospital Affiliated to Fujian Medical University, Ningde 355000, Fujian Province, China
Zhao-Yun Liu, Department of Gastroenterology, Ningde Municipal Hospital, Ningde 352100, Fujian Province, China
Co-first authors: Jing Lu and Zhao-Yun Liu.
Author contributions: Lu J and Liu ZY designed the study, curated the data, performed the statistical analyses, interpreted the findings, and drafted the manuscript, both authors have made crucial and indispensable contributions towards the completion of the project and thus qualified as the co-first authors of the paper; Guo C contributed to the methodological design, clinical interpretation, study supervision, and critical revision of the manuscript; Gong QQ conceived and supervised the study, interpreted the findings, critically revised the manuscript, and coordinated submission.
AI contribution statement: During manuscript revision, ChatGPT (OpenAI, GPT-6) was used to assist with editorial wording, verification of publicly available source links, and table formatting. All AI-assisted revisions were reviewed and verified by the authors, who take full responsibility for the accuracy, integrity, and scientific content of the manuscript.
Supported by Fujian University of Traditional Chinese Medicine, No. XB2024208.
Institutional review board statement: The National Health and Nutrition Examination Survey protocols were approved by the National Center for Health Statistics Research Ethics Review Board. The present study used only publicly available, deidentified secondary data and did not involve renewed contact with participants.
Informed consent statement: All participants provided written informed consent in the original National Health and Nutrition Examination Survey cycles.
Conflict-of-interest statement: The authors declare no conflicts of interest related to this study.
STROBE statement: The authors have read the STROBE Statement, and the manuscript was prepared and revised in accordance with the STROBE reporting recommendations for observational studies.
Data sharing statement: The National Health and Nutrition Examination Survey data and the 2019 public-use linked mortality files used in this study are publicly available from the National Center for Health Statistics. The 2019 Continuous NHANES Public-use Linked Mortality Files and supporting documentation are accessible through the NCHS data linkage portal (https://www.cdc.gov/nchs/linked-data/mortality-files/index.html). No new restricted dataset was generated. The analytic R scripts and a reproducibility README are provided in the Supplementary Code package.
Corresponding author: Qing-Quan Gong, MD, Adjunct Associate Professor, Department of Gastroenterology, Mindong Hospital Affiliated to Fujian Medical University, No. 89 Heshan Road, Ningde 355000, Fujian Province, China. gqq96398@sina.com
Received: June 15, 2026
Revised: August 25, 2026
Accepted: November 5, 2026
Published online: November 27, 2026
Processing time: 158 Days and 0.5 Hours
Abstract
BACKGROUND

The hepatic steatosis index (HSI) and fibrosis-4 index (FIB-4) are readily calculated from routinely collected clinical data; they share aminotransferase components, while FIB-4 is also strongly influenced by age and platelet count. We hypothesized that the association between FIB-4 and mortality would vary across established HSI screening categories and that combining the indices would provide limited incremental prognostic information.

AIM

To evaluate associations between FIB-4 and mortality across HSI categories and assess the incremental predictive value of both indices.

METHODS

This retrospective cohort study included adults aged ≥ 45 years who participated in the 1999-2018 National Health and Nutrition Examination Survey, with mortality follow-up through 2019. HSI was categorized as < 30, 30-36, or > 36, and elevated FIB-4 was defined using age-specific thresholds. HSI and FIB-4 were surrogate indices, and the primary cohort lacked imaging or histologic confirmation of steatotic liver disease or fibrosis. Mortality associations were evaluated using survey-weighted Cox models, restricted cubic splines, and period-specific models. Incremental prediction was evaluated using Harrell’s C-index, time-dependent area under the receiver operating characteristic curve, Brier score, and apparent calibration. Missing-data robustness was assessed using multiple imputation.

RESULTS

Among 27197 participants (6654 deaths), the fully adjusted complete-case model included 21695 participants (5079 deaths), excluding 5502 participants with missing covariate data. Fully adjusted hazard ratios for elevated vs low FIB-4 were 1.132 (95%CI: 0.931-1.376), 1.350 (1.223-1.491), and 1.173 (1.063-1.295) in the HSI < 30, 30-36, and > 36 groups, respectively. The overall interaction was not statistically significant (P = 0.098). Both indices showed nonlinear associations with mortality. Period-specific estimates were not statistically significant beyond 10 years of follow-up, and effect modification was not consistent over time. The pooled interaction remained statistically nonsignificant after multiple imputation (P = 0.056). Adding both indices to the base clinical model increased Harrell’s C-index by 0.00319 (95%CI: 0.00190-0.00447), whereas adding their interaction provided no further improvement.

CONCLUSION

Elevated FIB-4 was associated with mortality in HSI 30-36 and > 36, but not significantly in HSI < 30; the overall interaction was nonsignificant, and predictive improvement did not establish clinical utility.

Keywords: Hepatic steatosis index; Fibrosis-4 index; All-cause mortality; National Health and Nutrition Examination Survey; Risk assessment; Survival analysis

Core Tip: Elevated fibrosis-4 index (FIB-4) was associated with higher all-cause mortality within the hepatic steatosis index (HSI) 30-36 and > 36 categories, but the overall interaction was not statistically significant. The observed gains in predictive performance were statistically detectable but small and do not establish clinical utility. Because HSI and FIB-4 share aminotransferase components and FIB-4 is influenced by age and platelet count, elevated FIB-4 should be interpreted as a composite risk marker rather than direct evidence of advanced liver fibrosis.

Write to the Help Desk